Back to results
US 2005/0090504 A1Published application
Piperidinyl and piperazinyl compounds substituted with bicyclo-heterocyclylalkyl groups useful as CCR3 receptor antagonists
OwnerLeyi Gong, Robert Wilhelminventors
Life of this patent
Estimating the term…
Abstract
Compounds having the Formula (I), are useful as CCR3 receptor antagonists, wherein Ar is aryl or heteroaryl; Q is —C(═O)— or C1-2alkylene; X is N(+)R9a, or N; Y is CR9b, or N; R2 is hydrogen or alkyl; R3 and R4 are as defined in the specification; Uc is a mono- or bicyclic group as defined in the specification; n is 0 or 1; and p is 0, 1, 2, 3 or 4.
Claims21
A compound having the Formula (I):
- wherein:
- Ar is aryl or heteroaryl;
- Q is —C(═O)— or C1-2alkylene;
- X is N, or N+R9a Z−;
- Y is CR9a or N;
- Z is a pharmaceutically acceptable anion;
- R2 is hydrogen or alkyl;
- R3 and R4 are, independently of each other, hydrogen, C1-8 alkyl, substituted alkyl, C2-8 alkenyl, C3-7 cycloalkyl, aryl, heteroaryl, heterocyclyl, heteroalkyl, —(C1-8 alkylene)-C(═O)-Z1, or —(C1-8alkylene)-C(O)2Z1, wherein Z1 is C1-8 alkyl, C1-8 haloalkyl, C1-8 alkoxy, C1-8 haloalkoxy, hydroxy, amino, alkylamino, aryl, aryl C1-8 alkyl, aryloxy, aryl C1-8 alkyloxy, heteroaryl, or heteroaryloxy;
- Uc is selected from one of (S), (T), (V), and (W),
- wherein T1 is O, S, or NR5, wherein R5 is selected from hydrogen, C1-8 alkyl, substituted C1-8 alkyl, C3-7 cycloalkyl, and heterocyclyl;
- and V1 and W1 define an optionally substituted five-to-six membered heterocyclic ring;
- provided that when Uc is T and T1 is S, then at least one of R3 and R4 is not hydrogen, and further provided that when both X and Y are N, Uc is not T;
- R9 is attached to any available carbon atom of the piperidinyl or piperazinyl ring and is selected from the group consisting of hydroxy, lower alkoxy, oxo (═O), halogen, cyano, halo C1-4 alkyl, halo C1-4 alkoxy, and C1-4 lower alkyl optionally substituted with one to two R15;
- R9a and R9b are selected from the group consisting of hydrogen and C1-8 alkyl optionally substituted with one to two R15;
- R10 is attached to any available carbon atom of the benzo or phenyl ring and at each occurrence is independently selected from the group consisting of C1-8 alkyl, substituted C1-8 alkyl, hydroxy, C1-8 alkoxy, halogen, cyano, C1-8 haloalkoxy, amino, alkylamino, heterocyclyl, heteroaryl, C3-7 cycloalkyl, or phenyl said heterocyclyl, heteroaryl, C3-7 cycloalkyl and phenyl bring optionally substituted by one to three substituents independently selected from R16;
- R15 at each occurrence is independently selected from the group consisting of hydroxy, C1-4 alkoxy, halo, cyano, trifluoromethyl, trifluoromethoxy, amino, and alkylamino;
- R16 at each occurrence is independently selected from the group consisting of C1-4 alkyl, hydroxy, C1-4 alkoxy, halo, cyano, trifluoromethyl, trifluoromethoxy, amino, and alkylamino;
- m is 0, 1, 2, 3, or 4;
- n is 0 or 1;
- p is 0, 1, 2, 3 or 4;
- and,
- pharmaceutically-acceptable salts thereof.
19 more elements
Dependencies are inferred from the claim text.